lidocaine 2% — Class II drug recall D-1074-2023
Terminated recall by Central Admixture Pharmacy Services Inc, reported 2023-08-09, distributed nationwide. Lack of assurance of sterility: Lack of validation data for sanitization cycles
| Recall number | D-1074-2023 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Central Admixture Pharmacy Services Inc, San Diego, CA, United States |
| Recall initiated | 2023-07-17 |
| Classified | 2023-08-03 |
| Reported by FDA | 2023-08-09 |
| Terminated | 2025-03-21 |
| Distributed | Nationwide (US) |
| Quantity | 9,517 syringes |
| Reason classes | sterility |
| NDC | 71286-6006-01 |
| Lot numbers | 17-271076, 17-271132, 17-271165, 17-271230, 17-271250, 17-271508, 17-271595, 17-271604, 17-271658, 17-271764, 17-271826, 17-271972, 17-272052, 17-272057, 17-272139, 17-272258, 17-272470, 17-272690, 17-272822, 17-273054, 17-273065, 17-273423, 17-273771 |
| Expiration dates | 2023-07-24, 2023-07-25, 2023-07-26, 2023-07-31, 2023-08-01, 2023-08-02, 2023-08-03, 2023-08-06, 2023-08-08, 2023-08-09, 2023-08-10, 2023-08-14, 2023-08-16, 2023-08-20, 2023-08-23, 2023-08-28, 2023-09-02, 2023-09-07 |
Product
lidocaine 2%, 100 mg /5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1
Reason for recall
Lack of assurance of sterility: Lack of validation data for sanitization cycles
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-1074-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.